Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial.
Kellerer M, Kaltoft MS, Lawson J, Nielsen LL, Strojek K, Tabak Ö, Jacob S. Kellerer M, et al. Among authors: strojek k. Diabetes Obes Metab. 2022 Sep;24(9):1788-1799. doi: 10.1111/dom.14765. Epub 2022 Jun 29. Diabetes Obes Metab. 2022. PMID: 35546450 Free PMC article. Clinical Trial.
Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes.
Russell-Jones D, Dauchy A, Delgado E, Dimitriadis G, Frandsen HA, Popescu L, Schultes B, Strojek K, Bonnemaire M, Roborel de Climens A, Davies M. Russell-Jones D, et al. Among authors: strojek k. Diabetes Obes Metab. 2019 Jul;21(7):1615-1624. doi: 10.1111/dom.13697. Epub 2019 Apr 30. Diabetes Obes Metab. 2019. PMID: 30851006 Free PMC article. Clinical Trial.
Aerobic as well as resistance exercises are good for patients with type 1 diabetes.
Wróbel M, Rokicka D, Czuba M, Gołaś A, Pyka Ł, Greif M, Szymborska-Kajanek A, Strojek K, Gąsior M. Wróbel M, et al. Among authors: strojek k. Diabetes Res Clin Pract. 2018 Oct;144:93-101. doi: 10.1016/j.diabres.2018.08.008. Epub 2018 Aug 16. Diabetes Res Clin Pract. 2018. PMID: 30121304 Clinical Trial.
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. Barnett AH, et al. Among authors: strojek k. Diabetes Obes Metab. 2008 Dec;10(12):1239-47. doi: 10.1111/j.1463-1326.2008.00894.x. Epub 2008 May 20. Diabetes Obes Metab. 2008. PMID: 18494813 Clinical Trial.
Self-monitoring of blood glucose in treatment of type 2 diabetes.
Szymborska-Kajanek A, Psurek A, Hese R, Strojek K. Szymborska-Kajanek A, et al. Among authors: strojek k. Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S49-52. doi: 10.1016/S0168-8227(09)70009-9. Diabetes Res Clin Pract. 2009. PMID: 20115932 Review.
139 results